A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
Clinical trial NCT01814748 · COMPLETED
Trial details
- NCT number
- NCT01814748
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-03
- Primary completion
- 2015-09-14
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.